Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-04 Sale | 2024-01-05 4:07 pm | KALA BIO Inc. | KALA | Trachtenberg Eric SEE REMARKS | 1,227 | $6.74 | $8,270 | 88,566 (Direct) | View |
| 2024-01-04 Sale | 2024-01-05 4:06 pm | KALA BIO Inc. | KALA | Kharabi Darius CHIEF BUSINESS OFFICER | 1,385 | $6.73 | $9,321 | 85,617 (Direct) | View |
| 2024-01-04 Sale | 2024-01-05 4:05 pm | KALA BIO Inc. | KALA | Brazzell Romulus K SEE REMARKS | 1,617 | $6.74 | $10,899 | 120,773 (Direct) | View |
| 2024-01-04 Sale | 2024-01-05 4:04 pm | KALA BIO Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 4,539 | $6.73 | $30,547 | 350,815 (Direct) | View |
| 2024-01-04 Sale | 2024-01-05 4:04 pm | KALA BIO Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 1,227 | $6.74 | $8,270 | 86,636 (Direct) | View |
| 2024-01-04 Sale | 2024-01-05 4:03 pm | KALA BIO Inc. | KALA | Bazemore Todd SEE REMARKS | 1,405 | $6.74 | $9,470 | 119,087 (Indirect Direct) | View |
| 2023-01-04 Sale | 2023-01-06 8:00 pm | Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS | 60 | $28.55 | $1,713 | 11,495 (Direct) | View |
| 2023-01-04 Sale | 2023-01-06 8:00 pm | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 60 | $28.54 | $1,712 | 11,883 (Direct) | View |
| 2023-01-04 Sale | 2023-01-06 8:00 pm | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS | 73 | $28.53 | $2,083 | 18,536 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-04 Option Award | 2024-01-05 4:07 pm | N/A 2034-01-03 | KALA BIO Inc. | KALA | Trachtenberg Eric SEE REMARKS | 25,100 | $0 | 88,566 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-05 4:06 pm | N/A 2034-01-03 | KALA BIO Inc. | KALA | Kharabi Darius CHIEF BUSINESS OFFICER | 25,100 | $0 | 85,617 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-05 4:05 pm | N/A 2034-01-03 | KALA BIO Inc. | KALA | Brazzell Romulus K SEE REMARKS | 35,800 | $0 | 120,773 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-05 4:04 pm | N/A 2034-01-03 | KALA BIO Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 78,800 | $0 | 350,815 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-05 4:04 pm | N/A 2034-01-03 | KALA BIO Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 25,100 | $0 | 86,636 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-05 4:03 pm | N/A 2034-01-03 | KALA BIO Inc. | KALA | Bazemore Todd SEE REMARKS | 35,800 | $0 | 119,087 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-23 8:00 pm | N/A 2033-06-21 | Kala Pharmaceuticals Inc. | KALA | Farid Marjan Director | 12,214 | $0 | 13,814 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-23 8:00 pm | N/A 2033-06-21 | Kala Pharmaceuticals Inc. | KALA | Myers C. Daniel Director | 12,430 | $0 | 14,070 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-23 8:00 pm | N/A 2033-06-21 | Kala Pharmaceuticals Inc. | KALA | KOVEN ANDREW I Director | 22,085 | $0 | 25,342 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-23 8:00 pm | N/A 2033-06-21 | Kala Pharmaceuticals Inc. | KALA | Rosen Howard B Director | 22,239 | $0 | 25,803 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-23 8:00 pm | N/A 2033-06-21 | Kala Pharmaceuticals Inc. | KALA | Kharabi Darius CHIEF BUSINESS OFFICER | 85,976 | $0 | 111,031 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-23 8:00 pm | N/A 2033-06-21 | Kala Pharmaceuticals Inc. | KALA | PERRY GREGORY D Director | 17,264 | $0 | 19,802 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-23 8:00 pm | N/A 2033-06-21 | Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS | 87,637 | $0 | 114,771 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-23 8:00 pm | N/A 2033-06-21 | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 84,336 | $0 | 110,955 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-23 8:00 pm | N/A 2033-06-21 | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS | 115,164 | $0 | 151,616 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-23 8:00 pm | N/A 2033-06-21 | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS | 113,629 | $0 | 149,623 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-23 8:00 pm | N/A 2033-06-21 | Kala Pharmaceuticals Inc. | KALA | Blumenkranz Mark S. Director | 12,430 | $0 | 188,967 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-23 8:00 pm | N/A 2033-06-21 | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 370,704 | $0 | 488,385 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Rosen Howard B Director | 2,502 | $0 | 3,564 (Direct) | View |
| 2023-05-31 Disposition | 2023-06-02 8:00 pm | N/A 2024-10-02 | Kala Pharmaceuticals Inc. | KALA | Rosen Howard B Director | 2,502 | $0 | 3,564 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Farid Marjan Director | 1,600 | $0 | 1,600 (Direct) | View |
| 2023-05-31 Disposition | 2023-06-02 8:00 pm | N/A 2032-10-30 | Kala Pharmaceuticals Inc. | KALA | Farid Marjan Director | 1,600 | $0 | 1,600 (Direct) | View |
| 2023-03-10 Option Award | 2023-06-02 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Kharabi Darius CHIEF BUSINESS OFFICER | 9,625 | $0 | 25,064 (Direct) | View |
| 2022-02-15 Other | 2023-06-02 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Kharabi Darius CHIEF BUSINESS OFFICER | 9 | $0 | 25,064 (Direct) | View |
| 2023-05-31 Disposition | 2023-06-02 8:00 pm | N/A 2031-11-14 | Kala Pharmaceuticals Inc. | KALA | Kharabi Darius CHIEF BUSINESS OFFICER | 2,648 | $0 | 25,064 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | PERRY GREGORY D Director | 1,738 | $0 | 2,538 (Direct) | View |
| 2023-05-31 Disposition | 2023-06-02 8:00 pm | N/A 2028-02-28 | Kala Pharmaceuticals Inc. | KALA | PERRY GREGORY D Director | 1,738 | $0 | 2,538 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS | 15,639 | $0 | 27,134 (Direct) | View |
| 2023-05-31 Disposition | 2023-06-02 8:00 pm | N/A 2028-04-04 | Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS | 15,639 | $0 | 27,134 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Myers C. Daniel Director | 1,640 | $0 | 1,640 (Direct) | View |
| 2023-05-31 Disposition | 2023-06-02 8:00 pm | N/A 2031-10-14 | Kala Pharmaceuticals Inc. | KALA | Myers C. Daniel Director | 1,640 | $0 | 1,640 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | KOVEN ANDREW I Director | 2,197 | $0 | 3,257 (Direct) | View |
| 2023-05-31 Disposition | 2023-06-02 8:00 pm | N/A 2027-09-28 | Kala Pharmaceuticals Inc. | KALA | KOVEN ANDREW I Director | 2,197 | $0 | 3,257 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 14,736 | $0 | 26,619 (Direct) | View |
| 2023-05-31 Disposition | 2023-06-02 8:00 pm | N/A 2025-06-17 | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 14,736 | $0 | 26,619 (Direct) | View |
| 2023-03-10 Option Award | 2023-06-02 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Blumenkranz Mark S. Director | 69,784 | $0 | 8,156 (Direct) | View |
| 2023-02-15 Other | 2023-06-02 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Blumenkranz Mark S. Director | 73 | $0 | 8,156 (Direct) | View |
| 2023-05-31 Disposition | 2023-06-02 8:00 pm | N/A 2031-11-14 | Kala Pharmaceuticals Inc. | KALA | Blumenkranz Mark S. Director | 1,640 | $0 | 8,156 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS | 17,916 | $0 | 36,452 (Direct) | View |
| 2023-05-31 Disposition | 2023-06-02 8:00 pm | N/A 2025-10-02 | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS | 17,916 | $0 | 36,452 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS | 21,158 | $0 | 35,994 (Direct) | View |
| 2023-05-31 Disposition | 2023-06-02 8:00 pm | N/A 2027-11-19 | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS | 21,158 | $0 | 35,994 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 71,715 | $0 | 117,681 (Direct) | View |
| 2023-05-31 Disposition | 2023-06-02 8:00 pm | N/A 2025-06-03 | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 71,715 | $0 | 117,681 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-15 8:00 pm | N/A 2032-01-03 | Kala Pharmaceuticals Inc. | KALA | Kharabi Darius CHIEF BUSINESS OFFICER | 432 | $0 | 432 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-15 8:00 pm | N/A 2032-01-03 | Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS | 432 | $0 | 432 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-15 8:00 pm | N/A 2032-01-03 | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 432 | $0 | 432 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-15 8:00 pm | N/A 2032-01-03 | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS | 576 | $0 | 576 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-15 8:00 pm | N/A 2032-01-03 | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS | 576 | $0 | 576 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-15 8:00 pm | N/A 2032-01-03 | Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER | 1,512 | $0 | 1,512 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-06 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Kharabi Darius CHIEF BUSINESS OFFICER | 9,525 | $0 | 15,439 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-06 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS | 9,525 | $0 | 11,495 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-06 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 9,525 | $0 | 11,883 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-06 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS | 12,800 | $0 | 18,536 (Direct) | View |